Get started
Author

Emad N. Ibrahim

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 587
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
2023 · H. Borghaei, F. de Marinis, et al. · Annals of Oncology · 103
PDF
Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
2013 · Ignace B. Vergote, Agustin Garcia, et al. · Journal of Clinical Oncology · 47
PDF
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy
2016 · James Wang, Kyle A. Udd, et al. · Supportive Care in Cancer · 39
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer
2020 · Douglas W. Blayney, Qingyuan Zhang, et al. · JAMA Oncology · 31
PDF
Long‐Term Treatment with Glucocorticoids Increases Synthesis and Stability of Junctional Acetylcholine Receptors on Innervated Cultured Human Muscle
1993 · Serge Braun, Valerie Askanas, et al. · Journal of Neurochemistry · 30
Abstract CT128: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients (pts) with HER2+ early-stage breast cancer (eBC): the CONTROL trial
2017 · Emad Ibrahim, Debu Tripathy, et al. · Cancer Research · 20
An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer
2018 · Jeffrey L. Vacirca, Arlene Chan, et al. · Cancer Medicine · 12
PDF
CLR 131 (Iopofosine I-131) Treatment in Triple Class Refractory and Beyond Multiple Myeloma Patients: Preliminary Efficacy and Safety Results from the Phase 2 Clover-1 Trial
2021 · Sikander Ailawadhi, Patrick Stiff, et al. · Blood · 7
Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
2019 · Sikander Ailawadhi, Patrick J. Stiff, et al. · Blood · 6
Works count: 12
Citation count: 882
H-index: 8
I10-index: 8
Year
Topic
Type